Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Athenahealth Inc (ATHN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,481,944
  • Shares Outstanding, K 40,608
  • Annual Sales, $ 1,220 M
  • Annual Income, $ 53,100 K
  • 36-Month Beta 0.75
  • Price/Sales 4.24
  • Price/Cash Flow 25.57
  • Price/Book 5.12
  • Price/Earnings ttm 37.39
  • Earnings Per Share ttm 3.61
  • Most Recent Earnings 1.08 on 11/09/18
  • Next Earnings Date 02/07/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.80
  • Number of Estimates 1
  • High Estimate 0.80
  • Low Estimate 0.80
  • Prior Year 0.93
  • Growth Rate Est. (year over year) -13.98%

Price Performance

See More
Period Period Low Period High Performance
1-Month
133.00 +1.50%
on 01/14/19
135.00 -0.01%
on 02/11/19
+1.61 (+1.21%)
since 01/11/19
3-Month
129.00 +4.64%
on 12/24/18
135.00 -0.01%
on 02/11/19
+14.64 (+12.16%)
since 11/09/18
52-Week
116.77 +15.60%
on 10/12/18
163.94 -17.66%
on 06/06/18
+3.92 (+2.99%)
since 02/09/18

Most Recent Stories

More News
Athenahealth (ATHN) Earnings Expected to Grow: Should You Buy?

Athenahealth (ATHN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ATHN : 134.99 (+0.01%)
Here's Why Investors Should Retain athenahealth (ATHN) Stock

athenahealth (ATHN) gains from a broad product portfolio. However, it faces stiff competition in the MedTech space.

ATHN : 134.99 (+0.01%)
BDX : 249.06 (+0.41%)
VEEV : 118.00 (-1.99%)
OPK : 2.75 (-2.48%)
Cerner (CERN) Teams Up With Nebraska-Based LRHC, Shares Up

Cerner's (CERN) coveted Millennium platform has seen rising demand in recent times.

CERN : 57.77 (+0.40%)
ATHN : 134.99 (+0.01%)
BDX : 249.06 (+0.41%)
MDRX : 12.16 (+0.16%)
Integra LifeSciences Unveils Titan RSS-S, Widens Portfolio

The latest launch reflects Integra LifeSciences' (IART) consistent efforts to boost the Orthopedics and Tissue Technologies segment.

SRDX : 58.24 (+1.61%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)
IART : 51.93 (+1.49%)
Report: Exploring Fundamental Drivers Behind Akamai Technologies, Dynex Capital, MedEquities Realty Trust, HFF, Penumbra, and athenahealth -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Akamai Technologies, Inc. (NASDAQ:AKAM),...

DX : 6.03 (-0.50%)
ATHN : 134.99 (+0.01%)
AKAM : 69.83 (-0.91%)
PEN : 149.00 (-1.47%)
MRT : 10.61 (-0.84%)
HF : 42.59 (+0.76%)
Integra (IART) Rises 5% on Robust Preliminary Q4 Results

Integra's (IART) total Q4 revenues are likely to be at the upper end of its prior guided range.

SRDX : 58.24 (+1.61%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)
IART : 51.93 (+1.49%)
Boston Scientific Gains on Impressive Preliminary Q4 Results

Boston Scientific's (BSX) solid top line is expected to be backed by growth across all segments and geographical regions in Q4.

SRDX : 58.24 (+1.61%)
BSX : 40.11 (+0.63%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)
ResMed Announces Complete Mobi Launch in US Markets for COPD

ResMed (RMD) progresses with efforts to boost Respiratory Care suite.

SRDX : 58.24 (+1.61%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)
RMD : 99.77 (+0.02%)
QIAGEN Scores on Strategic Alliances, Suffers Low HPV Sales

QIAGEN (QGEN) pins high hopes on its strategic tie-ups with Hamilton and DiaSorin. It unveils a CE-marked DiaSorin automation solution in Europe to use the LIAISON system for test read-out.

SRDX : 58.24 (+1.61%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)
QGEN : 38.95 (+0.83%)
Hologic Stock Rides on Impressive Preliminary Q1 Result

Hologic's (HOLX) strong top line is primarily expected on the back of balanced growth across a majority of the company's segments in Q1.

HOLX : 46.42 (+0.28%)
SRDX : 58.24 (+1.61%)
ATHN : 134.99 (+0.01%)
VEEV : 118.00 (-1.99%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade ATHN with:

Business Summary

ATHENAHEALTH INC is a leading provider of internet-based business services for physician practices. The Company's service offerings are based on proprietary web-native practice management and electronic medical record software, a continuously updated payer knowledge-base and integrated back-office service...

See More

Key Turning Points

2nd Resistance Point 135.02
1st Resistance Point 135.00
Last Price 134.99
1st Support Level 134.97
2nd Support Level 134.96

See More

52-Week High 163.94
Fibonacci 61.8% 145.92
Fibonacci 50% 140.35
Last Price 134.99
Fibonacci 38.2% 134.79
52-Week Low 116.77

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar